Taiwan FDA registration 1f284dd6e7d396f7039717e613b28343

"Bidi" anti-human bone marrow peroxidase reagent

TW: "必帝" 抗人類骨髓過氧化酶試劑
Taiwan flagTaiwan·Risk Class 2·BD BIOSCIENCES IMMUNOCYTOMETRY SYSTEMS, A UNIT OF BECTON, DICKINSON AND COMPANY·Registered Jul 03, 2006 – Jul 03, 2011Cancelled
Registration details
Analysis ID
1f284dd6e7d396f7039717e613b28343
Customs Code
DHA00601718500
Company information
Manufacturer Country
United States
Product details
Intended Use
The "BDI" anti-human MPO reagent reacts with human intracellular MPO.
Product Type (Level 1)
B Hematology, pathology, and genetics
Product Type (Level 2)
B.4020 Analysis of specific tests
Import Information
import
Dates and status
Registration Date
Jul 03, 2006
Expiry Date
Jul 03, 2011
Cancellation Date
Oct 26, 2012
Cancellation information
Status
Logged out
Reason
許可證已逾有效期
About this record

Access comprehensive regulatory information for "Bidi" anti-human bone marrow peroxidase reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 1f284dd6e7d396f7039717e613b28343 and manufactured by BD BIOSCIENCES IMMUNOCYTOMETRY SYSTEMS, A UNIT OF BECTON, DICKINSON AND COMPANY. The authorized representative in Taiwan is Taiwan Branch of American Business Bidi Co., Ltd.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices